Pancreatic Cancer Research

ResearcherWest Virginia UniversityActive in the last 2 years

Timothy D. Eubank

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8225-7824; OpenAlex author ID A5032051684. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 8

  1. Exploratory single-nucleus multiomics analysis of myeloid cell states associated with neoadjuvant chemotherapy response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ctm2.70810↗
  2. Neutrophil extracellular trap inhibition revitalizes PDAC immunotherapy responsiveness via reduced fibrosis and TCF1+CD8+ progenitor T-cell expansion. Co-author DOI 10.1080/2162402x.2025.2601394↗
  3. Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/2326-6066.cir-24-0534↗
  4. Analysis of single nuclear chromatin accessibility reveals unique myeloid populations in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ctm2.1595↗
  5. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. First author DOI 10.3390/biom11060901↗
  6. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Last author DOI 10.3390/cancers14010194↗
  7. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Co-author DOI 10.1158/0008-5472.can-12-4601↗
  8. Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients Co-author DOI 10.1186/2051-1426-1-s1-p163↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian A. Boone · 6 shared papers, 2021–2026 · strength 1.32
  2. Hillary G. Pratt · 4 shared papers, 2021–2026 · strength 0.86
  3. Alyson M. Stevens · 2 shared papers, 2025–2026 · strength 0.50
  4. Mercy Mayowa Ojetunde · 2 shared papers, 2025–2026 · strength 0.50
  5. Britney R. Niemann · 2 shared papers, 2025 · strength 0.50
  6. Kawther Abdilleh · 1 shared paper, 2026 · strength 0.27
  7. Ramiz S. Ahmad · 1 shared paper, 2021 · strength 0.19
  8. Wendy L. Frankel · 2 shared papers, 2013 · strength 0.07
  9. Mark Bloomston · 2 shared papers, 2013 · strength 0.07
  10. Thomas A. Mace · 2 shared papers, 2013 · strength 0.07
  11. Tanios Bekaii‐Saab · 2 shared papers, 2013 · strength 0.07
  12. Gregory B. Lesinski · 2 shared papers, 2013 · strength 0.07
  13. Mitch A. Phelps · 1 shared paper, 2013 · strength 0.03
  14. Thomas Ludwig · 1 shared paper, 2013 · strength 0.03
  15. Michael C. Ostrowski · 1 shared paper, 2013 · strength 0.03
  16. Amy Collins · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.